A Real-world Clinical Study of T-DXd for the Treatment of Chinese Patients With HER2 Overexpressing and HER2 Underexpressing Advanced Breast Cancer
Clinical trial NCT07035353 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07035353
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-06-30
- Primary completion
- 2028-05-01
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.